The investment manager has taken the time to review the recently published ELSA paper on estimating gross returns acknowledging it as another refreshing step in the right direction of bringing uniformity of methodologies and expectations in assessing the emerging Life Settlement Asset class.
It correctly brings into focus the disciplines of Uniform Medical Underwriting and Uniform methodologies of Financial Analysis to assist investors (and Managers) in making more informed decisions in the crucial decision process of allocating capital to asset purchases. The value opportunities presented by this market are compelling as well as the opportunity to further diversify a larger asset allocation.
The analysis of the paper has noted a few considerations which were not addressed in the study and points out why prices for seemingly identical polices may vary.
To investigate this topic further please continue on to the Investment Manager’s Blog.
*This post originally published 1 April 2015
Disclaimer: This information is intended for qualifying investors only and was correct at the time of preparation. It has been prepared to provide general information only and should not be considered as a “securities recommendation” or an “invitation to invest” in any jurisdiction. Potential investors should consider the relevance of this information to their particular circumstances. Before proceeding investors must obtain the prospectus and take their own legal and taxation advice. If you acquire or hold one of our products we will receive fees and other benefits as disclosed in the prospectus and relevant offering documents.